Bausch Health Companies Inc
BHC
Company Profile
Business description
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Contact
2150 St Elzear Boulvard West
LavalQCH7L 4A8
CANT: +1 514 744-6792
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
20,700
Stocks News & Analysis
stocks
Picking dividend shares in 2026? Here’s where to look
A new report from Morningstar shows opportunities for income investors.
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
With outstanding long-term estimates, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,915.70 | 38.20 | 0.43% |
| CAC 40 | 8,142.16 | 27.93 | -0.34% |
| DAX 40 | 23,765.54 | 111.01 | -0.46% |
| Dow JONES (US) | 47,147.48 | 309.74 | -0.65% |
| FTSE 100 | 9,684.55 | 13.82 | -0.14% |
| HKSE | 26,384.28 | 188.18 | -0.71% |
| NASDAQ | 22,900.59 | 30.23 | 0.13% |
| Nikkei 225 | 50,323.91 | 52.62 | -0.10% |
| NZX 50 Index | 13,499.04 | 34.58 | 0.26% |
| S&P 500 | 6,734.11 | 3.38 | -0.05% |
| S&P/ASX 200 | 8,636.40 | 32.30 | 0.38% |
| SSE Composite Index | 3,972.03 | 18.46 | -0.46% |